<DOC>
	<DOCNO>NCT01261611</DOCNO>
	<brief_summary>The purpose study evaluate well new drug call Dysport RU work safe , use treatment cervical dystonia . Dysport RU compare approve drug call Dysport .</brief_summary>
	<brief_title>Study Comparing Short Term Efficacy Dysport® Dysport RU® Placebo , Assess Efficacy Safety Dysport RU® Subjects With Cervical Dystonia</brief_title>
	<detailed_description />
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<criteria>Dystonia least 18 month duration since onset . Previously untreated Botulinum toxinA ( BTXA ) B minimum 14 week since last injection . TWSTRS score baseline : Total score ≥ 30 , Severity SubScale score ≥ 15 , Disability SubScale score ≥ 3 , Pain SubScale score ≥ 2 . Known hypersensitivity Botulinum toxin ( BTX ) relate compound component study drug formulation ( include cow milk protein ) . Pure anterocollis pure retrocollis . In apparent remission Cervical Dystonia . Known clinically significant underlie swallow respiratory abnormality might exacerbate BTX treatment . Previous poor response BTX treatment know presence BTX neutralising antibody . Previous phenol alcohol injection neck muscle . Previous myotomy denervation surgery involve neck shoulder region .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>